BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 33153822)

  • 21. Role of axillary lymph node ultrasound and large core biopsy in the preoperative assessment of patients selected for sentinel node biopsy.
    Nori J; Bazzocchi M; Boeri C; Vanzi E; Nori Bufalini F; Mangialavori G; Distante V; Masi A; Simoncini R; Londero V
    Radiol Med; 2005 Apr; 109(4):330-44. PubMed ID: 15883518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selection for axillary clearance in breast cancer (ultrasound negative, sentinel node positive patients have low rates of further metastases).
    Nath J; Sami N; Massey J; Donnelly J; Corder AP
    Eur J Surg Oncol; 2013 May; 39(5):450-4. PubMed ID: 23433860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns in the Use of Axillary Operations for Patients with Node-Positive Breast Cancer After Neoadjuvant Chemotherapy: A National Cancer Database (NCDB) Analysis.
    Srour MK; Tseng J; Luu M; Alban RF; Giuliano AE; Chung A
    Ann Surg Oncol; 2019 Oct; 26(10):3305-3311. PubMed ID: 31342364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic value of sentinel lymph node micrometastases in patients with invasive breast carcinoma.
    Cipolla C; Graceffa G; La Mendola R; Fricano S; Fricano M; Vieni S
    Ann Ital Chir; 2015; 86():497-502. PubMed ID: 26898168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population based study on sentinel node biopsy before or after neoadjuvant chemotherapy in clinically node negative breast cancer patients: Identification rate and influence on axillary treatment.
    van der Heiden-van der Loo M; de Munck L; Sonke GS; van Dalen T; van Diest PJ; van den Bongard HJ; Peeters PH; Rutgers EJ
    Eur J Cancer; 2015 May; 51(8):915-21. PubMed ID: 25857549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Axillary Lymph Node Ultrasound Following Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: Results from the SN FNAC Study.
    Morency D; Dumitra S; Parvez E; Martel K; Basik M; Robidoux A; Poirier B; Holloway CMB; Gaboury L; Sideris L; Meterissian S; Boileau JF
    Ann Surg Oncol; 2019 Dec; 26(13):4337-4345. PubMed ID: 31605348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sentinel node biopsy for axillary management after neoadjuvant therapy for breast cancer: a single-center retrospective analysis with long follow-up.
    Ogawa Y; Ikeda K; Watanabe C; Kamei Y; Tokunaga S; Tsuboguchi Y; Inoue T; Fukushima H; Ichiki M
    Surg Today; 2018 Jan; 48(1):87-94. PubMed ID: 28647776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer with axillary node metastasis: A survey of clinical practice.
    Lee SB; Yu JH; Park H; Kim HJ; Park SH; Chae BJ; Youn HJ; Jung SY; Kim EK; Jung YS; Son BH
    Asian J Surg; 2019 Jan; 42(1):314-319. PubMed ID: 30049563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Value of preoperative ultrasound-guided axillary lymph node biopsy for preventing completion axillary lymph node dissection in breast cancer: a systematic review and meta-analysis.
    Diepstraten SC; Sever AR; Buckens CF; Veldhuis WB; van Dalen T; van den Bosch MA; Mali WP; Verkooijen HM
    Ann Surg Oncol; 2014 Jan; 21(1):51-9. PubMed ID: 24008555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Axillary lymph node dissection in breast cancer patients after sentinel node biopsy.
    Jessing C; Langhans L; Jensen MB; Talman ML; Tvedskov TF; Kroman N
    Acta Oncol; 2018 Jan; 57(1):166-169. PubMed ID: 29168429
    [No Abstract]   [Full Text] [Related]  

  • 31. Ten-year report on axillary recurrence after negative sentinel node biopsy for breast cancer from the Swedish Multicentre Cohort Study.
    de Boniface J; Frisell J; Bergkvist L; Andersson Y;
    Br J Surg; 2017 Feb; 104(3):238-247. PubMed ID: 28052310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contrast-Enhanced Ultrasound Biopsy of Sentinel Lymph Nodes in Patients with Breast Cancer: Implications for Axillary Metastases and Conservation.
    Cox K; Weeks J; Mills P; Chalmers R; Devalia H; Fish D; Sever A
    Ann Surg Oncol; 2016 Jan; 23(1):58-64. PubMed ID: 25990967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Axillary nodal burden in primary breast cancer patients with positive pre-operative ultrasound guided fine needle aspiration cytology: management in the era of ACOSOG Z011.
    Boland MR; Prichard RS; Daskalova I; Lowery AJ; Evoy D; Geraghty J; Rothwell J; Quinn CM; O'Doherty A; McDermott EW
    Eur J Surg Oncol; 2015 Apr; 41(4):559-65. PubMed ID: 25648466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The significance of sentinel lymph node micrometastasis in breast cancer: Comparing outcomes with and without axillary clearance.
    Youssef MMG; Cameron D; Pucher PH; Olsen S; Ferguson D
    Breast; 2016 Dec; 30():101-104. PubMed ID: 27668857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of axillary ultrasound examination in the selection of breast cancer patients for sentinel node biopsy.
    Nori J; Vanzi E; Bazzocchi M; Bufalini FN; Distante V; Branconi F; Susini T
    Am J Surg; 2007 Jan; 193(1):16-20. PubMed ID: 17188081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sentinel lymph node biopsy in Chinese patients with large operable breast cancer (≥4 cm): A decade's experience from a single institution.
    Yang Y; He Y; Fan Z; Ouyang T
    Breast; 2017 Dec; 36():20-24. PubMed ID: 28869832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sentinel node biopsy after neoadjuvant treatment in breast cancer: Five-year follow-up of patients with clinically node-negative or node-positive disease before treatment.
    Galimberti V; Ribeiro Fontana SK; Maisonneuve P; Steccanella F; Vento AR; Intra M; Naninato P; Caldarella P; Iorfida M; Colleoni M; Viale G; Grana CM; Rotmensz N; Luini A
    Eur J Surg Oncol; 2016 Mar; 42(3):361-8. PubMed ID: 26746091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Towards rational axillary treatment in relation to neoadjuvant therapy in breast cancer.
    Straver ME; Rutgers EJ; Russell NS; Oldenburg HS; Rodenhuis S; Wesseling J; Vincent A; Peeters MT
    Eur J Cancer; 2009 Sep; 45(13):2284-92. PubMed ID: 19464164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
    Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minimal access breast surgery: a single breast incision for breast conservation surgery and sentinel lymph node biopsy.
    Spillane AJ; Brennan ME
    Eur J Surg Oncol; 2009 Apr; 35(4):380-6. PubMed ID: 18757165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.